Funding for this research was provided by:
National Natural Science Foundation of China (31970748, 81925012, 92049301)
Science and Technology Commission of Shanghai Municipality (20JC1410900, 18410722100)
Received: 14 January 2021
Accepted: 18 June 2021
First Online: 8 July 2021
Change Date: 9 August 2021
Change Type: Update
Change Details: In Fig. 2b of the manuscript, the "DMSO" was printed twice with partial overlap. Now it has been corrected in both pdf and html version of the article.
: The authors have filed both Chinese and PCT patents based on this study. BL and YD are shareholders of biotech companies on targeted degradation relevant drug development research.